Monday, February 7, 2022
1859 Finds $40M For AI Powered Biotech
San Diego-based 1859, a biotech startup which says it is combining artificial intelligence with small molecule medicine screening, said on Monday that it has raised $40M in a Series A funding round. The funding came from Northpond Ventures, OMX Ventures, plus FusionX Ventures and Vertical Venture Partners. The company said the funding will go
The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.